UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): November
26, 2007
PLURISTEM
THERAPEUTICS INC.
|
(Exact
name of registrant as specified in its
charter)
|
NEVADA
|
|
001-31392
|
|
98-0351734
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
MATAM
Advanced Technology Park, Building No. 20, Haifa, Israel
|
|
31905
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
+972-74-710-7171
(Registrant’s
telephone number, including area code)
PLURISTEM
LIFE SYSTEMS, INC.
|
(Former
name or former address, if changed since last
report.)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[
]
Written communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
[
]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
[
]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
8.01 Other Events.
On
November 26, 2007, the registrant issued a press release announcing the
effectiveness of its reverse stock split and change of name to Pluristem
Therapeutics Inc., as well as its new trading symbol. A copy of the Press
Release is attached hereto as Exhibit 99.1 and incorporated by reference
herein.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
99.1
Press release issued by the registrant on November 26, 2007
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
PLURISTEM
THERAPEUTICS INC.
(registrant)
|
|
|
|
|
By: |
/s/ Zami Aberman |
|
|
|
Date: November 26, 2007 |
|
|
|
|
Name:
Zami Aberman
Title:
Chief Executive Officer
|